Schrödinger Q2 revenue rises 16% to $54.8 million; net loss narrows to $43.2 million
Schrödinger reported second-quarter 2025 total revenue of $54.8 million, up 16% from a year earlier, and a net loss of $43.2 million, narrower than the $54.0 million loss in the second quarter of 2024. The company kept its 2025 revenue growth guidance and lowered its operating expense outlook, though software gross margin fell to 68% from 80%.
Key points
- Total revenue rose 16% to $54.8 million from $47.3 million; software revenue rose 15% to $40.5 million.
- Net loss was $43.2 million versus $54.0 million a year earlier; software gross margin fell to 68% from 80%.
- Software revenue growth guidance of 10% to 15% and drug discovery revenue guidance of $45 million to $50 million were reaffirmed; operating expense guidance was lowered and 2025 operating expenses are now expected to be lower than 2024.
The filing
Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.